Recently, a pan-HER (HER is a part of the EGFR family) inhibitor, dacomitinib, and PI3K/mTOR inhibitor, gedatolisib, successfully attenuated tumor growth in combination with radiation therapy in xenograft models. This evidence concerns the gene EGFR and neoplasm.